PACIRA BIOSCIENCES, INC. Earnings Per Share, Basic and Diluted
PACIRA BIOSCIENCES, INC. (PCRX) reported Earnings Per Share, Basic and Diluted of $0.19 per share for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-05-07
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was $0.19.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.12, a 158.49% decline year-over-year.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.15.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was $0.07, a 16.67% increase year-over-year.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.27.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.01.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.07.
- PACIRA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.02.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-03-31 | $0.19 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.26 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.27 10-K · filed 2020-02-21 | |
| 2019-09-30 | -$0.15 10-Q · filed 2019-11-08 | -$0.15 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $0.07 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | -$0.07 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.20 10-K · filed 2020-02-21 | $0.19 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$0.01 10-K · filed 2020-02-21 | |
| 2018-09-30 | -$0.02 10-K · filed 2020-02-21 | -$0.21 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $0.06 10-K · filed 2020-02-21 | -$0.20 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$0.26 10-K · filed 2020-02-21 | -$0.15 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$0.34 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$0.83 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2017-12-31 | $0.11 10-K · filed 2019-02-28 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$0.56 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$1.07 10-K · filed 2020-02-21 |
| 2017-09-30 | -$0.19 10-K · filed 2019-02-28 | -$0.68 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.19 10-Q · filed 2018-11-01 | -$1.31 derived: net income ÷ weighted average shares · filed 2019-02-28 |
| 2017-06-30 | -$0.49 10-K · filed 2019-02-28 | -$1.01 10-Q · filed 2018-08-02 | -$1.13 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.72 derived: net income ÷ weighted average shares · filed 2019-02-28 |
| 2017-03-31 | -$0.52 10-K · filed 2019-02-28 | -$0.63 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.22 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.44 derived: net income ÷ weighted average shares · filed 2019-02-28 |
| 2016-12-31 | -$0.11 10-K · filed 2018-02-28 | -$0.70 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.91 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.02 10-K · filed 2019-02-28 |
| 2016-09-30 | -$0.59 10-K · filed 2018-02-28 | -$0.81 derived: net income ÷ weighted average shares · filed 2018-02-28 | -$0.91 10-Q · filed 2017-11-08 | |
| 2016-06-30 | -$0.21 10-K · filed 2018-02-28 | -$0.32 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | -$0.10 10-K · filed 2018-02-28 | |||
| 2015-12-31 | -$0.07 10-K · filed 2017-03-01 | |||
| 2015-09-30 | $0.08 10-K · filed 2017-03-01 | |||
| 2015-06-30 | $0.00 10-K · filed 2017-03-01 | $0.03 10-Q · filed 2015-07-30 | ||
| 2015-03-31 | $0.03 10-K · filed 2017-03-01 | |||
| 2014-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.46 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.61 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.39 10-K · filed 2015-02-24 |
| 2014-09-30 | -$0.08 10-Q · filed 2014-10-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$0.56 10-Q · filed 2014-10-30 | -$0.91 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-06-30 | -$0.14 10-Q · filed 2015-07-30 | -$0.48 10-Q · filed 2015-07-30 | -$0.83 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.27 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-03-31 | -$0.34 10-Q · filed 2015-04-30 | -$0.70 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.14 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.56 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2013-12-31 | -$0.36 10-K · filed 2014-02-25 | -$0.80 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.22 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.93 10-K · filed 2015-02-24 |
| 2013-09-30 | -$0.44 10-Q · filed 2014-10-30 | -$0.87 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.57 10-Q · filed 2014-10-30 | -$2.07 derived: net income ÷ weighted average shares · filed 2015-02-24 |
| 2013-06-30 | -$0.42 10-Q · filed 2014-07-31 | -$1.13 10-Q · filed 2014-07-31 | -$1.63 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$2.12 derived: net income ÷ weighted average shares · filed 2015-02-24 |
| 2013-03-31 | -$0.71 10-Q · filed 2014-05-01 | -$1.21 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.70 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.97 derived: net income ÷ weighted average shares · filed 2015-02-24 |
| 2012-12-31 | -$0.50 10-K · filed 2014-02-25 | -$0.99 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.26 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.72 10-K · filed 2015-02-24 |
| 2012-09-30 | -$0.49 10-K · filed 2014-02-25 | -$0.76 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$1.21 10-Q · filed 2013-10-31 | -$1.86 derived: net income ÷ weighted average shares · filed 2014-02-25 |
| 2012-06-30 | -$0.27 10-K · filed 2014-02-25 | -$0.72 10-Q · filed 2013-08-06 | -$1.37 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$1.90 derived: net income ÷ weighted average shares · filed 2014-02-25 |
| 2012-03-31 | -$0.47 10-K · filed 2014-02-25 | -$1.17 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$1.72 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$2.24 derived: net income ÷ weighted average shares · filed 2014-02-25 |
| 2011-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$1.29 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$1.81 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$2.64 10-K · filed 2014-02-25 |
| 2011-09-30 | -$0.55 10-Q · filed 2012-11-01 | -$1.06 derived: net income ÷ weighted average shares · filed 2012-11-01 | -$1.89 10-Q · filed 2012-11-01 | |
| 2011-06-30 | -$0.51 10-Q · filed 2012-08-09 | -$1.36 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | -$0.98 10-Q · filed 2012-05-09 | |||
| 2010-12-31 | -$47.29 10-K · filed 2013-03-07 | |||
| 2010-09-30 | -$13.77 10-Q · filed 2011-10-31 | -$35.02 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$11.86 10-Q · filed 2011-08-11 | -$21.25 10-Q · filed 2011-08-11 | ||
| 2009-12-31 | -$55.32 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |